Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
US Lawmaker's $45,000 Stock Acquisition Highlights Congressional Investment Practices in Biotech Sector
Representative April McClain Delaney, a Democrat from Maryland, has made significant equity purchases totaling approximately $45,000, with strategic allocations to two prominent biotechnology companies. The investment moves—comprising up to $30,000 in Labcorp Holdings Inc. (LH) and up to $15,000 in Bio-Techne Corp. (TECH)—have drawn attention from investment tracking platforms monitoring congressional stock transactions.
The Congressional-Biotech Connection
Delaney’s board seat on the House Agriculture Committee’s Subcommittee on Conservation, Research, and Biotechnology creates particular interest in her biotech sector holdings. While both companies operate within life sciences, they serve distinct market segments. Labcorp provides diagnostic laboratory services, genomic analysis, and pharmaceutical development support infrastructure. Bio-Techne, by contrast, manufactures and distributes research reagents, analytical instruments, and bioprocessing tools directly to the research community.
Regulatory Framework and Transparency
Under the STOCK Act’s requirements, members of Congress must publicly disclose equity transactions exceeding $1,000 within a 45-day window through periodic filings. Delaney’s transactions fully comply with these disclosure obligations. The legislative framework permits lawmakers to maintain stock portfolios in regulated industries, provided transparency standards are met.
Additional Portfolio Activity
Beyond the biotech focus, Delaney’s recent transaction history includes purchases of BJ’s Wholesale Club (BJ), Brown & Brown (BRO), Nasdaq Inc. (NDAQ), Paychex (PAYX), and Tractor Supply (TSCO). Concurrent partial position reductions involved Fortune Brands (FBIN), IDEXX Labs (IDXX), Teledyne Technologies (TDY), and Middleby Corp (MIDD), reflecting portfolio rebalancing across multiple sectors.
The investment activity underscores how congressional stock trading, when conducted transparently within regulatory parameters, remains a normal aspect of lawmaker financial management.